Evidence map›Paper›PMID 40401254›Full record

ArticleJournal of patient experience2025

Patient and Cardiologist Perspectives on the Treatment of Patients With Concomitant ASCVD and Obesity.

Pam Taub, Michael G Knight, Delilah McCarty, Carey Robar, Andrea Traina, Lyn Behnke

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of patient experience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pam TaubDivision of Cardiovascular Medicine, University of California at San Diego, San Diego, CA, USA.
Michael G KnightDepartment of Medicine, The George Washington University, Washington, DC, USA.
Delilah McCartyNovo Nordisk, Inc., Plainsboro, NJ, USA.
Carey RobarNovo Nordisk, Inc., Plainsboro, NJ, USA.
Andrea TrainaNovo Nordisk, Inc., Plainsboro, NJ, USA.
Lyn BehnkeWomenHeart, Washington, DC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atherosclerotic cardiovascular disease (ASCVD) and obesity pose challenges to patients, healthcare professionals (HCPs), and health systems. The aim of this study was to understand the journey of patients with ASCVD and obesity, their caregivers, and managing HCPs to optimize treatment outcomes. Patients with ASCVD and body mass index ≥ 27 kg/m

Indexed as

antiobesity medicationsASCVDatherosclerotic cardiovascular diseasebiascardiologycardiovascular diseasesethnic and racial minoritiesobesityobesity managementphysician–patient relations

Identifiers

PMID40401254
PMCPMC12093011

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.